The Vital Role of Genetic Testing for Black Patients in HCM

Hypertrophic cardiomyopathy (HCM), while seemingly uncommon, actually impacts approximately one in 250 to 500 individuals in the U.S., as per the Cleveland Clinic. Remarkably, many remain unaware of their condition until symptoms manifest or a serious cardiac incident occurs. HCM constitutes a heart ailment wherein the heart muscle thickens, hindering effective blood circulation and, in severe scenarios, obstructing blood flow entirely. If you've recently received a diagnosis, you may question its genetic underpinnings; indeed, the condition is largely hereditary. Dr. Maran Thamilarasan from the Cleveland Clinic notes that about 60 percent of HCM cases involve identifiable genetic mutations. Furthermore, Black patients often face delayed diagnoses and misdiagnosis, complicating management and heightening risks for serious complications. Genetic testing, especially for immediate family, is vital in this scenario. Engage with your healthcare provider about potential tests, symptoms, and lifestyle modifications, as proactive measures can significantly improve outcomes and quality of life.